Monday, November 29, 2021

MeiraGTx to Provide a Xerostomia Clinical Program Update - GlobeNewswire

LONDON and NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy.
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2021/11/29/2342533/0/en/MeiraGTx-to-Provide-a-Xerostomia-Clinical-Program-Update-and-Host-a-Virtual-Research-and-Development-Day-on-Gene-Regulation.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFSLkI3XCds15I7xgdcAytPGL8NyA
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...